These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5394452)

  • 21. 4-Azolylpyridine 1-oxides. Analogs of the hypoglycemic 4-azolylpyridinium salts.
    Bauer VJ; Fanshawe WJ; Wiegand GE; Safir SR
    J Med Chem; 1969 Sep; 12(5):945-6. PubMed ID: 5812231
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoglycemic quaternary azolylpyridinium salts. Inactive analogs.
    Bauer VJ; Wiegand GE; Fanshawe WJ; Safir SR
    J Med Chem; 1969 Sep; 12(5):944-5. PubMed ID: 5812230
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypoglycemic action of some antidiabetics in spinal dogs].
    Suzuki H
    Nihon Ika Daigaku Zasshi; 1969; 36(1):55-60. PubMed ID: 5768300
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypoglycemic cyclic amidines.
    Barsky LI; Bencze WL
    J Med Chem; 1971 Jan; 14(1):40-4. PubMed ID: 5539744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Relationship between structure and hypoglycemic activity in a series of amide substituted p-N-R-sulfamidooxanilic acids].
    Chernykh VP; Bannyĭ IP; Valiashko NN; Petiunin PA; Desenko VF
    Farmakol Toksikol; 1979; 42(1):51-5. PubMed ID: 421892
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
    Hasselblatt A; Panten U; Poser W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chemical structure and blood glucose lowering effect].
    Bänder A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():429-40. PubMed ID: 4906983
    [No Abstract]   [Full Text] [Related]  

  • 28. Derivatives of 4,5,6,7-tetrahydro-7,8,8-trimethyl-3-phenylamino-4,7-methano-2H-ind azo le with hypotensive and hypoglycemic activities. II.
    Ranise A; Bondavalli F; Schenone P; Lampa E; Greco R; Scafuro M; Marmo E
    Farmaco Sci; 1984 Mar; 39(3):200-7. PubMed ID: 6714414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Substances with antiviral activity. XV. Preparation and antiherpes activity of alkyl- and acylamino-dihalogenated pyrimidines and pyridines].
    Giovanninetti G; Garuti L; Cavrini V; Roveri P; Mannini Palenzona A; Sinibaldi P; Fusco PA
    Farmaco Sci; 1980 Oct; 35(10):879-86. PubMed ID: 6256211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of 3-[p-(N-2-pyrimidylsulfamoyl)phenyl hydrazono]pentane-2,4-dione on blood parameters of albino rats.
    Goyal RN; Garg DK
    Indian J Exp Biol; 1996 Oct; 34(10):982-6. PubMed ID: 9055650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycemic compounds. Amino acid derivatives of sulfonylurea. II.
    Vicentini CB; Guarneri M; Sarto G
    Farmaco Sci; 1983 Sep; 38(9):672-8. PubMed ID: 6641933
    [No Abstract]   [Full Text] [Related]  

  • 33. [Synthesis of pyrazole derivatives and pyrazolo[4,3-d]pyrimidines. I].
    Baraldi PG; Vicentini CB; Simoni D; Guarneri M
    Farmaco Sci; 1983 Jun; 38(6):370-5. PubMed ID: 6603373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies of intermediary metabolism under loading with glibenclamide].
    Schräpler P; Petrides P
    Arzneimittelforschung; 1969 Oct; 19(10):1729-31. PubMed ID: 5395375
    [No Abstract]   [Full Text] [Related]  

  • 35. Quaternary 4- (and 5-) azolylpyridazinium salts. A new class of oral hypoglycemic agents.
    Wiegand GE; Bauer VJ; Safir SR; Blickens DA; Riggi SJ
    J Med Chem; 1972 Dec; 15(12):1326-8. PubMed ID: 4635983
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
    Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
    [No Abstract]   [Full Text] [Related]  

  • 37. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z; Wójcikowski C
    Acta Pol Pharm; 1990; 47(3-4):45-8. PubMed ID: 12959242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On 2-benzolsulfonylamine-5(beta-methoxyethoxy)-pyrimidine (Glycodiazine). VI. Experiments on the mechanism of action of the oral antidiabetic Glycodiazine in healthy test persons].
    Gerhards E; Nieuweboer B; Gutsche H
    Arzneimittelforschung; 1968 May; 18(5):570-7. PubMed ID: 5756198
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacodynamics and studies on the mechanism of action of HB 419].
    Schmidt FH; Stork H; Bänder A; Pfaff W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1369-73. PubMed ID: 5394455
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of HB 419--a new oral antidiabetic--on fat metabolism].
    Stork H; Schmidt FH; Bänder A; Pfaff W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1373-8. PubMed ID: 5394456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.